Skip to main content

Advertisement

Log in

USA: Food and Drug Administration weitet Malignomwarnung für TNF-α-Inhibitor aus

Food and Drug Administration extends malignancy warning for TNF-α inhibitors

  • Leserbriefe
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Diel R, Hauer B, Loddenkemper R et al (2009) Empfehlungen für das Tuberkulose-Screening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen. Z Rheumatol 68:411–416

    Article  CAS  PubMed  Google Scholar 

  2. 2.FDA: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm174474.htm

  3. Kempen JH, Daniel E, Dunn JP et al (2009) Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drug: retrospective cohort study. Br Med J 339(31):b2490

    Article  Google Scholar 

  4. Arzneimittelkommission der deutschen Ärzteschaft: http://www.akdae.de/20/10/2009-071.html

  5. http://www.biologika-register.de

  6. AkdÄ-Berichtsbogen: http://www.akdae.de/en/20/905UAWBerichtsbogen.pdf

Download references

Interessenskonflikt

Der korrespondierende Autor gibt an, dass kein Interessenskonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Harten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harten, P. USA: Food and Drug Administration weitet Malignomwarnung für TNF-α-Inhibitor aus. Z. Rheumatol. 68, 857–858 (2009). https://doi.org/10.1007/s00393-009-0566-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-009-0566-8

Navigation